Tag: pfizer

With major logistical challenges, companies face a bottleneck in vaccine distribution

02.10.21.

The pace of vaccinations in the U.S. is failing to meet expectations, in part due to inadequate production and supply. But President Biden is planning to invoke the federal Defense Production Act in an effort to ensure companies, manufacturers and states get what they need. Miles O’Brien reports on what some companies are already doing…
Read More
How a COVID vaccine might work — and the challenges of distributing it

11.17.20.

As drug companies around the world rush to develop candidates for coronavirus vaccines, Pfizer announced encouraging early data from its own trials Monday. What do the preliminary results show, and even if they are borne out, what challenges remain with regard to production and distribution of the vaccine? Science correspondent Miles O’ Brien joins William…
Read More
What we know about the search for a COVID-19 vaccine — and what we don’t

07.23.20.

The question of when a COVID-19 vaccine might be available is perhaps the most pressing in the world. There have been a number of recent headlines on this front, including early but encouraging results from trials. And on Wednesday, the Trump administration awarded a contract to Pfizer and a German biotech firm to potentially deliver…
Read More